|
Delayed
Japan Exchange
22:30:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1,094.00 JPY | -0.18% |
|
+1.72% | -33.96% |
| 08-12 | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
| 08-12 | PeptiDream Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 907M | |||||
| 67.82B | |||||
| 63.22B | |||||
| 27.58B | - | ||||
| 26.06B | - | ||||
| 25.38B |
- Stock Market
- Stocks
- 4587 Stock
- Charts PeptiDream Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
